Detalhe da pesquisa
1.
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Lancet
; 399(10333): 1383-1390, 2022 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385695
2.
Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
JAMA
; 321(21): 2101-2112, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31162568
3.
Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial.
Respiration
; 92(6): 362-370, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27784026
4.
Case report: Subjective loss of performance after pulmonary embolism in an athlete- beyond normal values.
BMC Pulm Med
; 16: 21, 2016 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26821715
5.
Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.
J Am Coll Cardiol
; 83(6): 669-678, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325992
6.
Identification of International Society on Thrombosis and Haemostasis major and clinically relevant non-major bleed events from electronic health records: a novel algorithm to enhance data utilisation from real-world sources.
Int J Popul Data Sci
; 8(1): 2144, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38414540
7.
Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP).
NPJ Digit Med
; 5(1): 80, 2022 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35764796
8.
Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long-term study.
J Cachexia Sarcopenia Muscle
; 12(6): 1501-1512, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498427
9.
Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure Trials.
Digit Biomark
; 4(2): 45-59, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33083685
10.
Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study.
Heart
; 103(8): 592-598, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28100544
11.
Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study.
Int J Cardiol
; 175(2): 233-9, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24880481
12.
CT-proET1 predicts pulmonary hemodynamics in Scleroderma-associated pulmonary hypertension.
Clin Res Cardiol
; 104(6): 525-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25707764